Show simple item record

dc.contributor.authorMartinez-Pino, Isabelen_GB
dc.contributor.authorLuquero, Francisco Jen_GB
dc.contributor.authorSakoba, Kéïtaen_GB
dc.contributor.authorSylla, Souleymaneen_GB
dc.contributor.authorHaile, Melatworken_GB
dc.contributor.authorGrais, Rebecca Fen_GB
dc.contributor.authorCiglenecki, Izaen_GB
dc.contributor.authorQuilici, Marie-Laureen_GB
dc.contributor.authorPage, Anne-Laureen_GB
dc.date.accessioned2013-10-04T19:44:33Z
dc.date.available2013-10-04T19:44:33Z
dc.date.issued2013-08-15
dc.identifier.citationUse of a Cholera Rapid Diagnostic Test during a Mass Vaccination Campaign in Response to an Epidemic in Guinea, 2012. 2013, 7 (8):e2366 PLoS Negl Trop Disen_GB
dc.identifier.issn1935-2735
dc.identifier.pmid23967359
dc.identifier.doi10.1371/journal.pntd.0002366
dc.identifier.urihttp://hdl.handle.net/10144/302751
dc.description.abstractDuring the 2012 cholera outbreak in the Republic of Guinea, the Ministry of Health, supported by Médecins Sans Frontières - Operational Center Geneva, used the oral cholera vaccine Shanchol as a part of the emergency response. The rapid diagnostic test (RDT) Crystal VC, widely used during outbreaks, detects lipopolysaccharide antigens of Vibrio cholerae O1 and O139, both included in Shanchol. In the context of reactive use of a whole-cell cholera vaccine in a region where cholera cases have been reported, it is essential to know what proportion of vaccinated individuals would be reactive to the RDT and for how long after vaccination.
dc.language.isoenen
dc.publisherPublic Library of Scienceen_GB
dc.rightsArchived with thanks to PLoS Neglected Tropical Diseasesen_GB
dc.subjectCholeraen_GB
dc.subjectDiagnosticsen_GB
dc.subjectOutbreaksen_GB
dc.titleUse of a Cholera Rapid Diagnostic Test during a Mass Vaccination Campaign in Response to an Epidemic in Guinea, 2012en
dc.contributor.departmentEuropean Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden ; Epicentre, Paris, France.en_GB
dc.identifier.journalPLoS Neglected Tropical Diseasesen_GB
refterms.dateFOA2019-03-04T10:47:18Z
html.description.abstractDuring the 2012 cholera outbreak in the Republic of Guinea, the Ministry of Health, supported by Médecins Sans Frontières - Operational Center Geneva, used the oral cholera vaccine Shanchol as a part of the emergency response. The rapid diagnostic test (RDT) Crystal VC, widely used during outbreaks, detects lipopolysaccharide antigens of Vibrio cholerae O1 and O139, both included in Shanchol. In the context of reactive use of a whole-cell cholera vaccine in a region where cholera cases have been reported, it is essential to know what proportion of vaccinated individuals would be reactive to the RDT and for how long after vaccination.


Files in this item

Thumbnail
Name:
Martinez-Pino et al. - 2013 - ...
Size:
167.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record